🦠 microbiology

Gut complement C1q and C3 interact with Clostridioides difficile spores via CdeM and contribute to pathogenesis.

This study reveals that gut complement proteins C1q and C3 interact with *Clostridioides difficile* spores via the exosporium protein CdeM to facilitate epithelial entry and drive recurrent disease, while their absence accelerates recovery and attenuates recurrence.

Original authors: Pizarro-Guajardo, M., Brito-Silva, C., Castro-Cordova, P., Montes-BRavo, N., Callegari, E., Gil, F., Paredes-Sabja, D.

Published 2026-09-25

📖 4 min read☕ Coffee break read

CC BY 4.0

Original authors: Pizarro-Guajardo, M., Brito-Silva, C., Castro-Cordova, P., Montes-BRavo, N., Callegari, E., Gil, F., Paredes-Sabja, D.

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

Inside the human gut, a complex ecosystem of bacteria, immune cells, and chemical signals constantly negotiates the boundary between health and disease. Among the most dangerous residents is Clostridioides difficile, a bacterium that can cause severe, life-threatening diarrhea, especially after antibiotics wipe out the friendly microbes that usually keep it in check. This bacterium has a unique survival strategy: it forms spores, which are tough, dormant shells that can lie hidden in the intestine for long periods, waiting for the right moment to wake up and cause a new infection. While scientists have long known that the body's immune system produces a suite of proteins called complement to hunt down invaders, they assumed these proteins mostly circulated in the blood, far from the gut lining. The question remained whether these immune sentinels were actually present and active right where the bacteria live, and if so, whether they were helping the body fight the infection or, unexpectedly, helping the bacteria survive.

A team of researchers has now uncovered a surprising and counterintuitive relationship between the gut's immune system and these bacterial spores. By examining healthy and injured sections of the mouse intestine, they found that two specific immune proteins, known as C1q and C3, are indeed present and accessible on the surface of the gut lining. However, when the bacteria release toxins that damage the gut wall, the landscape changes dramatically: the amount of accessible C1q drops, while the amount of accessible C3 rises. More importantly, the researchers discovered that the bacterial spores do not just ignore these proteins; they actively grab onto them. Using high-powered microscopes and purified proteins, the team showed that the spores bind directly to both C1q and C3. This binding happens through a specific protein on the spore's outer shell called CdeM, which acts like a hook to latch onto the immune proteins.

What makes this discovery particularly striking is that the bacteria seem to be hijacking this immune interaction for their own benefit. In laboratory experiments, when spores were coated with these immune proteins, they were much more likely to stick to and enter the cells that line the intestine. When the researchers removed C1q or C3 from the mix, the spores struggled to get inside the cells. This suggests that the very proteins the body produces to defend itself are being used by the bacteria as a tool to breach the intestinal barrier and hide inside the tissue. The researchers also found that while the immune system processes these proteins on the spore surface, it fails to kill them; the spores remain perfectly viable and ready to cause trouble later.

The most compelling evidence for this mechanism came from studies using mice that were genetically unable to produce C1q. When these mice were infected with the bacteria, they suffered from the initial illness just like normal mice. However, as the infection progressed and they were treated with antibiotics, the mice lacking C1q recovered much faster and were far less likely to develop a recurring infection. In contrast, the normal mice, which had the full complement of immune proteins, struggled to clear the infection and experienced more frequent relapses. This indicates that the presence of C1q, rather than protecting the host, actually helps the bacteria establish a persistent foothold in the gut, leading to the difficult-to-treat recurrence that plagues many patients.

The study rules out the idea that the bacteria use their other surface proteins, known as BclA, to catch these immune proteins, a mechanism seen in other types of spore-forming bacteria. Instead, the research points squarely at CdeM as the key player in C. difficile. The findings suggest that the gut's immune environment is more complex than previously thought, with local immune proteins playing a dual role: they are present to defend the host, but the pathogen has evolved to exploit their presence to invade deeper into the tissue and ensure its own survival. This new understanding of how the bacteria interact with the gut's own defenses opens a fresh perspective on why these infections are so hard to cure and why they return, highlighting a potential new target for treatments that could stop the bacteria from using the body's own immune system against it.

Technical Summary: Gut Complement C1q and C3 Interact with Clostridioides difficile Spores via CdeM and Contribute to Pathogenesis

Problem Statement
Clostridioides difficile infection (CDI) is characterized by toxin-mediated epithelial injury and a high frequency of disease recurrence. Recurrence is largely driven by dormant spores that persist in the intestine and interact with the intestinal mucosa. While the mechanisms of spore-mucosa interaction are partially understood (involving fibronectin, vitronectin, and E-cadherin), the role of the gut complement system in this process remains poorly defined. Although complement components like C1q and C3 are known to be produced locally in the intestine, their accessibility at the luminal interface and their specific interactions with C. difficile spores during infection are unclear. Furthermore, it is unknown whether the complement system acts as a host defense mechanism against spores or if it is exploited by the pathogen to facilitate persistence and recurrence.

Methodology
The study employed a multi-faceted approach combining in vivo mouse models, in vitro cellular assays, and biochemical analyses:

In Vivo Models: Ligatured ileal loops in C57BL/6 mice were used to assess the accessibility of C1q and C3 in healthy mucosa and after exposure to the toxin TcdB. Additionally, a CDI mouse model utilizing antibiotic pretreatment and infection with C. difficile R20291 spores was used to compare disease progression and recurrence between wild-type and C1q-deficient mice.
Microscopy and Imaging: Three-dimensional confocal microscopy was used to map the spatial distribution of accessible versus total C1q and C3 in ileal tissues. Immunogold transmission electron microscopy (TEM) localized complement binding to the spore surface.
Biochemical Assays: Solid-phase binding assays measured the concentration-dependent interaction between purified human C1q/C3 and spores of various strains (including bclA mutants). Far-Western blotting coupled with mass spectrometry (MS) identified specific spore coat proteins interacting with complement.
Cellular Assays: Caco-2 intestinal epithelial cells were used to quantify spore adherence and internalization under conditions of normal human serum (NHS), serum depleted of C1q or C3, and reconstituted sera.
Protein Analysis: CdeM inclusion bodies (IBs) were generated to test direct interactions with complement proteins and their ability to adhere to and enter epithelial cells. Immunoblotting assessed C3 deposition and processing on spores versus vegetative cells.

Key Results

Complement Accessibility in Healthy and Injured Mucosa: C1q and C3 are present and accessible within the healthy ileal mucosa, exhibiting heterogeneous spatial distributions. TcdB intoxication differentially remodels this landscape: it decreases accessible C1q while increasing accessible C3 at higher toxin concentrations, despite maintaining or increasing total C1q pools and decreasing total C3 pools.
Direct Spore-Complement Interaction: C. difficile spores associate with accessible C1q and C3 in vivo. In vitro, purified human C1q and C3 bind directly to the spore exosporium. Immunogold TEM confirmed localization to the outer exosporium layer on both thin and thick exosporium morphotypes.
Identification of Interacting Proteins: While Bacillus anthracis spores rely on BclA for complement binding, C. difficile BclA proteins (BclA1, BclA2, BclA3) modulate but are not required for C1q or C3 binding. Far-Western analysis and MS identified CotE and CdeM as candidate complement-interacting proteins. Direct binding assays confirmed that CdeM inclusion bodies associate with both C1q and C3, with CdeM showing a higher apparent affinity (lower $K_d$ ) for C1q than intact spores.
Role in Spore Internalization: Pre-incubation of spores with NHS significantly enhanced their adherence to and internalization by Caco-2 cells. Depletion of either C1q or C3 markedly reduced spore internalization, and reconstitution with the respective purified protein partially restored entry. CdeM inclusion bodies also adhered to and entered epithelial cells, an interaction reduced by NHS, suggesting CdeM possesses intrinsic epithelial interaction capabilities.
C3 Processing and Viability: C3 (and its fragment C3dg) was selectively deposited and processed on the surface of spores but not vegetative cells. Despite this deposition, exposure to complement did not reduce spore viability, indicating spores resist complement-mediated lysis.
Impact of C1q Deficiency on Disease Course: In a murine CDI model, C1q deficiency did not alter the onset or initial severity of acute infection (weight loss and diarrhea). However, C1q-deficient mice recovered body weight more rapidly and exhibited significantly attenuated recurrent disease following vancomycin treatment compared to wild-type mice.

Significance and Claims
The paper claims to identify intestinal complement as a previously unrecognized component of the C. difficile spore–host interface. The authors posit that:

Host Defense Exploitation: The pathogen exploits host complement components (C1q and C3) to promote interactions with the intestinal barrier, specifically enhancing spore entry into epithelial cells. This suggests a mechanism where a host defense pathway is co-opted to facilitate persistence.
Molecular Mechanism: The cysteine-rich exosporium protein CdeM acts as a primary ligand for C1q and C3, distinct from the collagen-like BclA proteins used by B. anthracis.
Clinical Relevance: The study provides the first evidence that intestinal C1q influences the clinical course of CDI. Specifically, the absence of C1q accelerates recovery from the acute phase and markedly reduces the severity of recurrent disease, suggesting that C1q-dependent mechanisms may sustain mucosal injury or promote the persistence required for recurrence.

The authors conclude that the interaction between gut complement and spores, mediated by CdeM, contributes to spore persistence and disease recurrence, offering a new perspective on the host-pathogen interface in CDI.

More like this